Attributable length of stay, mortality risk and costs of bacterial healthcare-associated infections in Australia: a retrospective case-cohort study

  02 September 2020

Unbiased estimates of the health and economic impact of healthcare-associated infections (HAIs) are scarce and focus largely on patients with bloodstream infection (BSI). We sought to estimate the hospital length of stay (LOS), mortality and costs of HAIs and the differential effect on patients with an antimicrobial resistance (AMR) infection.

The health burden remains highest for BSIs, however the UTIs and respiratory tract infections (RTI) contributed most to the healthcare system expenditure.

Author(s): X J Lee, A J Stewardson, L J Worth, N Graves, T M Wozniak
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!